Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 81 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

vitamin d
monoclonal antibodies
major surgery
metastatic colorectal adenocarcinoma
tumor cells
Northwest Hospital Center
 (3.8 away) Contact site
  • 65 views
  • 18 Jun, 2021
  • +972 other locations
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment

The purpose of this study is to evaluate the efficacy and safety of [Lu-177]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT).

Chesapeake Urology Associates (CUA) P.A.
 (7.6 away) Contact site
  • 0 views
  • 05 Jun, 2021
  • +4 other locations
Study of AVB-S6-500 in Combination With Paclitaxel vs Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer

This is a Phase 3 study of AVB-S6-500 in combination with paclitaxel (Pac) in patients with platinum resistant recurrent ovarian cancer. This is a randomized, double-blind, placebo-controlled study to compare efficacy and tolerability of AVB-S6-500 in combination with Pac versus placebo plus Pac.

Greater Baltimore Medical Center
 (9.3 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +13 other locations
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

This randomized phase III trial studies how well imatinib mesylate and combination chemotherapy work in treating patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. Imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, work …

left ventricular fractional shortening
adult t-cell leukemia/lymphoma
mercaptopurine
leucovorin
acute leukemia
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 305 views
  • 14 Jun, 2021
  • +185 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency

heart failure
nt-probnp
b-type natriuretic peptide
ejection fraction
iron
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 5316 views
  • 16 May, 2021
  • +353 other locations
S0820 Adenoma and Second Primary Prevention Trial

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.

aspirin
unstable angina
anticoagulants
adenoma
rectal carcinoma
Kaiser Permanente-Woodlawn Medical Center
 (6.5 away) Contact site
  • 2518 views
  • 03 Mar, 2021
  • +1033 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

cancer vaccine
androgen suppression
antiandrogen therapy
androgens
external beam radiation therapy
Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 1420 views
  • 02 Jun, 2021
  • +78 other locations
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Sinusitis With or Without the Presence of Nasal Polyps

This is a 24-week randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of intranasal administration of 186 and 372 g twice daily (BID) of OPN-375 in subjects with chronic sinusitis (CS) with or without nasal polyps.

nasal polyp
nasal congestion
facial pain
rhinorrhea
asthma
Ear, Nose and Throat Associates at Greater Baltimore Medical Center
 (9.3 away) Contact site
  • 338 views
  • 16 Jun, 2021
  • +90 other locations
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

The purpose of this study is to assess the efficacy and safety of the combination of the polyadenosine 5'-diphosphoribose poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and pembrolizumab in the treatment of participants with mCRPC who have failed to respond to either abiraterone acetate or enzalutamide (but not both) and to chemotherapy. …

orchiectomy
antiandrogen therapy
tumor progression
androgens
docetaxel
Chesapeake Urology Research Associates ( Site 0076)
 (9.3 away) Contact site
  • 394 views
  • 16 Jun, 2021
  • +212 other locations
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP plus placebo.

Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 498 views
  • 26 Jan, 2021
  • +480 other locations